Next Article in Journal
68Ga-Labeled Cyclic NGR Peptide for MicroPET Imaging of CD13 Receptor Expression
Previous Article in Journal
Synthesis and in Vitro Antimicrobial Evaluation of New N-Heterocyclic Diquaternary Pyridinium Compounds
Previous Article in Special Issue
MicroRNAs and Bone Metastasis: A New Challenge
Article Menu

Export Article

Open AccessCommunication
Molecules 2014, 19(8), 11586-11599; doi:10.3390/molecules190811586

Expression Profile and Clinical Significance of MicroRNAs in Papillary Thyroid Carcinoma

1
Department of Oncological Surgery, Hangzhou First People's Hospital, Hangzhou 310006, China
2
Department of General Surgery, Wuxi Second People's Hospital, Wuxi 214000, China
3
Department of Oncological Surgery, Wushan District of Hangzhou First People's Hospital, Hangzhou Cancer Hospital, Hangzhou 310002, China
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Received: 16 June 2014 / Revised: 24 July 2014 / Accepted: 25 July 2014 / Published: 5 August 2014
(This article belongs to the Special Issue miRNAs as Probes to Monitor Cancer and Neurodegenerative Disorders)
View Full-Text   |   Download PDF [768 KB, uploaded 5 August 2014]   |  

Abstract

This study screened microRNAs (miRNAs) that are abnormally expressed in papillary thyroid carcinoma (PTC) tissues to identify PTC and nodular goiter and the degree of PTC malignancy. A total of 51 thyroid tumor tissue specimens paired with adjacent normal thyroid tissues were obtained from the Department of Surgical Oncology of Hangzhou First People’s Hospital from June-December 2011. miRNA expression profiles were examined by microarrays and validated by quantitative real-time PCR (qRT-PCR). Expression levels of the miRNAs were analyzed to assess if they were associated with selected clinicopathological features. Eleven miRNAs were significantly differentially expressed between nodular goiter and PTC and between highly invasive and low invasive PTC. miR-199b-5p and miR-30a-3p were significantly differentially expressed among the three groups. miR-30a-3p, miR-122-5p, miR-136-5p, miR-146b-5p and miR-199b-5p were selected for further study by qRT-PCR and miR-146b-5p, miR-199b-5p and miR-30a-3p were different between the PTC and nodular goiter groups. miR-199b-5p was over-expressed in PTC patients with extrathyroidal invasion and cervical lymph node metastasis. In conclusion miR-146b-5p, miR-30a-3p, and miR-199b-5p may serve as biomarkers for the diagnosis of PTC and miR-199b-5p is associated with PTC invasiveness. View Full-Text
Keywords: papillary thyroid carcinoma; miRNA; invasiveness papillary thyroid carcinoma; miRNA; invasiveness
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Peng, Y.; Li, C.; Luo, D.-C.; Ding, J.-W.; Zhang, W.; Pan, G. Expression Profile and Clinical Significance of MicroRNAs in Papillary Thyroid Carcinoma. Molecules 2014, 19, 11586-11599.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top